The ADARB1 gene helps fine tune RNA messages, especially in the brain, so nerve cells can send signals in a stable way. The protein made by this gene helps your cells edit certain RNA instructions before they are used. If the ADARB1 gene does not work properly, brain signaling may be disrupted, which can lead to developmental delay, seizures, low muscle tone, or unusual movements. Pathogenic variants in the ADARB1 gene are a rare cause of an inherited neurologic condition.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for making proteins, the parts of cells that carry out the work. Other genes mainly help direct when certain processes happen, where they happen, and how strongly they run. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a closer look at this topic, you can find more in the LearnHub.
Overview
ADARB1Gene function
What if the gene works
The ADARB1 gene helps edit RNA, a working copy cells use to make proteins. This fine tunes how some proteins work, especially in the brain, and supports normal nerve cell signaling.
Risk
What if the gene does not work
More disruptive variants in the ADARB1 gene can cause a rare brain condition with early seizures, developmental delay, and movement problems, while milder variants may lead to later onset or less severe features.
Treatment
What does that mean for your treatment
No ADARB1-specific treatment or management approach is currently established. The ADARB1 gene is being studied in early research as a possible biomarker of altered RNA editing in some brain conditions and cancers.
Gene function
What if the gene works
Inside your cells, the ADARB1 gene helps fine tune RNA, the working copy made from DNA. It does this by editing selected RNA letters after the message is written, which can change how that message is read. This small adjustment supports stable communication between cells, especially in the nervous system.
The ADARB1 protein attaches to folded stretches of RNA, especially places where the strand pairs with itself. This helps the cell choose specific spots for editing rather than changing RNA at random.
It changes selected adenosine letters to inosine, which cells read like a different RNA letter. This is a normal form of RNA editing that slightly adjusts how a message is interpreted.
Many important targets of the ADARB1 gene are active in nerve cells, where precise RNA editing in the brain supports steady signaling. By fine tuning messages for channels and receptors, it helps neurons communicate smoothly.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and are part of normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change the function of a gene more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ADARB1 gene can alter the protein’s shape, make it less stable, or weaken how it binds and edits RNA, so cells end up with less well-tuned RNA messages. Some changes leave partial activity, while more disruptive variants can cause little or no editing at key RNA sites. That range helps explain how ADARB1 gene variants affect RNA editing and why some people develop earlier or more marked developmental problems and seizures than others.
How variants are linked to conditions
Pathogenic variants in the ADARB1 gene cause a rare condition called ADARB1-related developmental and epileptic encephalopathy. People with this condition usually develop seizures early in life and may also have developmental delay, low muscle tone, feeding difficulties, movement differences, and intellectual disability. Because this is a single-gene condition, finding a disease-causing variant in the ADARB1 gene can confirm the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are common in the general population and are a normal feature of human biology. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors also play a role. In some situations, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce risk related to the ADARB1 gene. For many living with an ADARB1-related condition, risk is mainly tied to the gene change itself rather than clear lifestyle or environmental factors, and a doctor or genetic counselor can help explain personal risk.
Inheritance of ADARB1 variants
For families looking at the ADARB1 gene inheritance pattern, the well-established pattern is autosomal recessive. This means a person usually develops an ADARB1-related condition only when both copies of the ADARB1 gene carry a disease-causing variant, with one altered copy inherited from each parent. Parents who each carry one variant are often unaffected themselves. With each pregnancy, they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with neither familial variant.
What does my ADARB1 result mean for my family?
For families with a disease-causing ADARB1 result, the pattern is usually recessive, which means close relatives may also be carriers even if they are healthy. Brothers and sisters could have the same condition or carry the same gene change, so family testing may be relevant for relatives. This can also matter for future pregnancies, because both parents may carry the change without knowing it.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for variants in the ADARB1 gene usually uses a blood or saliva sample. A lab reads the gene's DNA code and compares it with the usual sequence to look for changes, and the report may show a pathogenic variant, a benign variant, or a change whose meaning is still unclear.
When should I consider getting a genetic test?
Genetic testing for the ADARB1 gene may be worth discussing if a baby or child has unexplained early seizures, low muscle tone, and major developmental delay, especially if similar problems run in the family. Testing can help confirm whether a change in ADARB1 is the cause and may clarify what it means for relatives.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it can tell you depends on the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small inherited differences can change how a drug is absorbed, broken down, moved through the body, or how strongly it acts at its target. This helps explain why the same treatment works well for one person, seems weaker in another, or causes more side effects in someone else. These differences are common and are one reason medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medicines. By looking at links between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medications, genes can influence how powerfully a drug works or how the body handles it. This information can support more informed, more personalized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the ADARB1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so general questions about medicines, side effects, or how well treatment is working are best discussed with your doctor or pharmacist.
History
In recent decades, awareness of the ADARB1 gene’s role has grown as scientists worked to understand RNA editing, a process that changes RNA messages after they are copied from DNA. ADARB1 became better known in the 1990s, when researchers studying brain chemistry identified it as one of the enzymes responsible for this editing step. From these first observations, research expanded steadily, linking ADARB1 to key experiments that showed RNA is not always a fixed copy of genetic information. This helped shift genetics beyond the older view that DNA instructions pass straight to proteins unchanged. Later work connected rare ADARB1 variants with neurologic conditions, giving the gene added clinical importance. Its history is closely tied to the wider story of how RNA editing became an accepted part of human biology.